As of 2023, the HIV-positive tuberculosis treatment success rate in Canada was positioned at 77%. The forecast for 2024 to 2028 indicates a modest increasing trend, with a rise from 78% in 2024 to 80% by 2028. The year-on-year percentage variation from 2024 to 2025 is expected to be 1.28%, followed by a stable period with no change until 2027, and a 1.27% increase in 2028. The compound annual growth rate (CAGR) over the five-year period is forecasted to average around 0.77% per year.
Future trends to watch for include the implementation of innovative treatment protocols and integrated care initiatives, which could further improve success rates. Monitoring policy changes or healthcare funding shifts will be essential as they can substantially impact treatment outcomes. Collaboration between healthcare providers for synchronized HIV and TB care could also influence future success rates positively.
